Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Topical chemotherapy for ocular surface squamous neoplasia: current status.

Sepulveda R, Pe'er J, Midena E, Seregard S, Dua HS, Singh AD.

Br J Ophthalmol. 2010 May;94(5):532-5. doi: 10.1136/bjo.2009.160820. Epub 2009 Sep 23. Review.

PMID:
19776089
2.

Ocular surface squamous neoplasia: a standard of care survey.

Stone DU, Butt AL, Chodosh J.

Cornea. 2005 Apr;24(3):297-300.

PMID:
15778602
3.

Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.

Rudkin AK, Muecke JS.

Br J Ophthalmol. 2011 Jul;95(7):947-50. doi: 10.1136/bjo.2010.186171. Epub 2011 Jan 20.

PMID:
21252085
4.

Topical chemotherapy for ocular surface squamous neoplasia.

Nanji AA, Sayyad FE, Karp CL.

Curr Opin Ophthalmol. 2013 Jul;24(4):336-42. doi: 10.1097/ICU.0b013e3283622a13. Review.

PMID:
23680759
5.

Topical medical therapies for ocular surface tumors.

Poothullil AM, Colby KA.

Semin Ophthalmol. 2006 Jul-Sep;21(3):161-9. Review.

PMID:
16912014
6.

Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.

Sturges A, Butt AL, Lai JE, Chodosh J.

Ophthalmology. 2008 Aug;115(8):1297-302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.

PMID:
18294690
7.

Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.

Rudkin AK, Dempster L, Muecke JS.

Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):20-5. doi: 10.1111/ceo.12377. Epub 2014 Sep 9.

PMID:
24995542
8.

Intralesional bevacizumab use for invasive ocular surface squamous neoplasia.

Paul S, Stone DU.

J Ocul Pharmacol Ther. 2012 Dec;28(6):647-9. doi: 10.1089/jop.2011.0244. Epub 2012 Aug 17.

PMID:
22900896
9.

Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.

Russell HC, Chadha V, Lockington D, Kemp EG.

Br J Ophthalmol. 2010 Oct;94(10):1316-21. doi: 10.1136/bjo.2009.176099. Epub 2010 Jun 8.

PMID:
20530655
10.

Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.

Viani GA, Fendi LI.

Arq Bras Oftalmol. 2017 Mar-Apr;80(2):131-136. doi: 10.5935/0004-2749.20170032. Review.

11.

Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.

Bahrami B, Greenwell T, Muecke JS.

Clin Exp Ophthalmol. 2014 May-Jun;42(4):317-22. doi: 10.1111/ceo.12184. Epub 2013 Sep 13.

PMID:
23927413
12.

Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.

Parrozzani R, Lazzarini D, Alemany-Rubio E, Urban F, Midena E.

Br J Ophthalmol. 2011 Mar;95(3):355-9. doi: 10.1136/bjo.2010.183244. Epub 2010 Aug 7.

PMID:
20693564
13.

Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.

Holcombe DJ, Lee GA.

Am J Ophthalmol. 2006 Oct;142(4):568-71.

PMID:
17011846
14.
15.

Ocular surface squamous neoplasia after corneal graft.

Ramasubramanian A, Shields CL, Sinha N, Shields JA.

Am J Ophthalmol. 2010 Jan;149(1):62-5. doi: 10.1016/j.ajo.2009.07.026. Epub 2009 Oct 20.

PMID:
19846060
16.

Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.

Huerva V, Mangues I.

J Fr Ophtalmol. 2008 Mar;31(3):317-25.

17.

Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.

Ashkenazy N, Karp CL, Wang G, Acosta CM, Galor A.

Cornea. 2017 Apr;36(4):506-510. doi: 10.1097/ICO.0000000000001153.

PMID:
28129301
18.

Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.

Rahimi F, Alipour F, Ghazizadeh Hashemi H, Hashemian MN, Mehrdad R.

Arch Iran Med. 2009 Jan;12(1):55-9.

19.
20.

Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.

Parrozzani R, Frizziero L, Trainiti S, Testi I, Miglionico G, Pilotto E, Blandamura S, Fassina A, Midena E.

Br J Ophthalmol. 2017 Aug;101(8):1094-1099. doi: 10.1136/bjophthalmol-2016-309219. Epub 2016 Dec 9.

Supplemental Content

Support Center